Punch & Associates Investment Management, Inc.
Source: SEC Form 13F · as of Mar 2026Punch & Associates Investment Management, Inc. holds 9 biotech & pharma companies tracked by BioSniper, totaling $94.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
9
Total value held
$94.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Royalty Pharma plc (RPRX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| RPRXRoyalty Pharma plc | 598,617 | $28.7M |
| IQVIQVIA Holdings Inc. | 88,490 | $15.1M |
| JNJJOHNSON & JOHNSON | 37,380 | $9.1M |
| NATRNATURES SUNSHINE PRODUCTS INC | 340,000 | $8.2M |
| MDXGMiMedx Group Inc | 2,019,718 | $8.0M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 26,956 | $7.3M |
| ELVElevance Health Inc. | 23,229 | $6.8M |
| AVNSAvanos Medical Inc. | 437,085 | $6.1M |
| VMDViemed Healthcare Inc. | 537,361 | $4.9M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.